ITBO940562A0 - Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi - Google Patents

Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Info

Publication number
ITBO940562A0
ITBO940562A0 ITBO940562A ITBO940562A ITBO940562A0 IT BO940562 A0 ITBO940562 A0 IT BO940562A0 IT BO940562 A ITBO940562 A IT BO940562A IT BO940562 A ITBO940562 A IT BO940562A IT BO940562 A0 ITBO940562 A0 IT BO940562A0
Authority
IT
Italy
Prior art keywords
lactones
atherosclerosis
antioxidant
therapy
activity useful
Prior art date
Application number
ITBO940562A
Other languages
English (en)
Inventor
Goffredo Rosini
Claudia Baldazzi
Eleonora Romagnoli
Stefano Sanguatti
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Publication of ITBO940562A0 publication Critical patent/ITBO940562A0/it
Priority to ITBO940562A priority Critical patent/IT1274355B/it
Priority to US08/556,648 priority patent/US5608084A/en
Priority to DK95118629T priority patent/DK0718295T3/da
Priority to ES95118629T priority patent/ES2115308T3/es
Priority to EP95118629A priority patent/EP0718295B1/en
Priority to DE69502168T priority patent/DE69502168T2/de
Priority to AT95118629T priority patent/ATE165354T1/de
Priority to JP7332407A priority patent/JP2820652B2/ja
Publication of ITBO940562A1 publication Critical patent/ITBO940562A1/it
Application granted granted Critical
Publication of IT1274355B publication Critical patent/IT1274355B/it
Priority to GR980400836T priority patent/GR3026702T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
    • C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
    • C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/76—Unsaturated compounds containing keto groups
    • C07C59/90—Unsaturated compounds containing keto groups containing singly bound oxygen-containing groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Peptides Or Proteins (AREA)
ITBO940562A 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi IT1274355B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi
US08/556,648 US5608084A (en) 1994-12-21 1995-11-13 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis
EP95118629A EP0718295B1 (en) 1994-12-21 1995-11-27 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis
ES95118629T ES2115308T3 (es) 1994-12-21 1995-11-27 Lactonas con actividad antioxidante e hipolipidemica, utiles en la terapia de la aterosclerosis.
DK95118629T DK0718295T3 (da) 1994-12-21 1995-11-27 Lactoner med antioxiderende og hypolipidæmisk virkning, hvilke lactoner er nyttige i terapien af atherosklerose
DE69502168T DE69502168T2 (de) 1994-12-21 1995-11-27 Lactone mit antioxidativer und hypolipidaemischer Wirkung zur Behandlung von Atherosklerose
AT95118629T ATE165354T1 (de) 1994-12-21 1995-11-27 Lactone mit antioxidativer und hypolipidaemischer wirkung zur behandlung von atherosklerose
JP7332407A JP2820652B2 (ja) 1994-12-21 1995-12-20 アテローム性動脈硬化症治療に有用な抗酸化活性および脂質低下活性を有するラクトン
GR980400836T GR3026702T3 (en) 1994-12-21 1998-04-23 Lactones with antioxidising and hypolipidaemic activity useful in the therapy of the atherosclerosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Publications (3)

Publication Number Publication Date
ITBO940562A0 true ITBO940562A0 (it) 1994-12-21
ITBO940562A1 ITBO940562A1 (it) 1996-06-21
IT1274355B IT1274355B (it) 1997-07-17

Family

ID=11340165

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO940562A IT1274355B (it) 1994-12-21 1994-12-21 Lattoni ad attivita' antiossidante ed ipolipidemica utili nella terapia dell'aterosclerosi

Country Status (9)

Country Link
US (1) US5608084A (it)
EP (1) EP0718295B1 (it)
JP (1) JP2820652B2 (it)
AT (1) ATE165354T1 (it)
DE (1) DE69502168T2 (it)
DK (1) DK0718295T3 (it)
ES (1) ES2115308T3 (it)
GR (1) GR3026702T3 (it)
IT (1) IT1274355B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001288294A1 (en) * 2000-08-21 2002-03-04 Merck And Co., Inc. Anti-hypercholesterolemic drug combination
DE10261067A1 (de) * 2002-12-24 2004-08-05 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Cholesterinsenkendes Mittel, enthaltend eine n-3-Fettsäure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674836A (en) * 1968-05-21 1972-07-04 Parke Davis & Co 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof
US4665091A (en) * 1985-11-04 1987-05-12 Merck & Co., Inc. Macrocyclic lactone HMG-CoA reductase inhibitors
US5196447A (en) * 1991-08-08 1993-03-23 Arizona Board Of Regents, A Body Corporate Of The State Of Arizona, Acting On Behalf Of Arizona State University Neristatin 1

Also Published As

Publication number Publication date
DE69502168D1 (de) 1998-05-28
JP2820652B2 (ja) 1998-11-05
JPH08231535A (ja) 1996-09-10
US5608084A (en) 1997-03-04
EP0718295A1 (en) 1996-06-26
ITBO940562A1 (it) 1996-06-21
ES2115308T3 (es) 1998-06-16
EP0718295B1 (en) 1998-04-22
DE69502168T2 (de) 1998-08-13
GR3026702T3 (en) 1998-07-31
ATE165354T1 (de) 1998-05-15
DK0718295T3 (da) 1999-01-11
IT1274355B (it) 1997-07-17

Similar Documents

Publication Publication Date Title
FI972580A7 (fi) Valmisteita ja menetelmiä ihoärsytyksen vähentämiseksi
BR8903526A (pt) Composicao de lubrificantes e aplicacao
FI964334L (fi) Polymeroitava koostumus ja sen käyttö
DE69028341D1 (de) Absorbierende Produkte und deren Herstellung
FI960635A7 (fi) Elektrodi ja sen valmistus
FI943345L (fi) Organo-aluminoksituotteet ja niiden käyttö
ZA947138B (en) Skin care method and composition
FI942993L (fi) Organoaluminoksituote ja sen käyttö
FI941787A7 (fi) Sähkökirurginen prosessori ja menetelmä sen käyttämiseksi
BR9611410A (pt) Método e composição farmacêutica para regular a concentração de lipídios
FI940640L (fi) Organoaluminoksituotteet ja käyttö
BR9307158A (pt) Mancal tendo almofadas separadas e metodos para fazer o mesmo
ZA9710569B (en) Novel benzamides and their application
FI951773A7 (fi) Alfa-animoalkaanihapot ja niiden pelkistymistuotteet
BR9502407A (pt) Composição lubrificante e concetrado
FI971750A0 (fi) Koostumuksia multippeliskleroosia varten ja sen hoito
AU2466695A (en) The use of famotidine and related compounds in the treatment of movement disorders
BR9608270A (pt) Composição compreendendo amoxicilina e acido clavulánico
BR9500630A (pt) Composição absorvente sólida e artigo fabricado incluindo uma composição absorvente sólida
FI951101L (fi) 5-vinyyli- ja 5-etinyylikinoloni- ja -naftyridonikarboksyylihapot
FI960134A7 (fi) Pyörivä leikkausmeisti ja menetelmä sen käyttämiseksi
DE59504748D1 (de) Polymerisierbare oligo- und/oder polyalkensäuren
FI944376L (fi) Menetelmä ja sovitelma muuton pysäyttämiseksi
BR9403702A (pt) Conjunto de revestimento contra desgaste e para lubrificação combinado
FI960706L (fi) Uusi proteiini ja menetelmiä proteiinin valmistamiseksi

Legal Events

Date Code Title Description
0001 Granted